Clozapine Tablet 25 mg

Here is a detailed overview of Clozapine Tablet 25 mg, without brand references:


๐Ÿ’Š Clozapine Tablet 25 mg


โœ… DESCRIPTION

Clozapine is an atypical antipsychotic primarily used in patients with treatment-resistant schizophrenia or those who experience suicidal behavior associated with psychotic disorders. It has a unique efficacy but requires close monitoring due to potential serious side effects.


๐Ÿงช FORMULATION

  • Active Ingredient: Clozapine 25 mg
  • Dosage Form: Tablet (oral)
  • Route of Administration: Oral
  • Packaging: Typically in blister packs or strips

๐ŸŒฟ NATURE

  • Drug Class: Atypical antipsychotic (Dibenzodiazepine derivative)
  • Mechanism of Action:
    • Antagonist at dopamine D2, serotonin 5-HT2A, histamine H1, alpha-adrenergic, and muscarinic receptors
    • Reduces positive and negative symptoms of schizophrenia

๐Ÿ’Š USES

  • Treatment-resistant schizophrenia (after failure of โ‰ฅ2 other antipsychotics)
  • Recurrent suicidal behavior in schizophrenia or schizoaffective disorder
  • May also be used off-label in bipolar disorder and psychosis in Parkinson’s disease

๐ŸŒŸ ADVANTAGES

  • Superior efficacy in resistant schizophrenia
  • Lower risk of extrapyramidal symptoms (e.g., tremors, rigidity)
  • Improves negative symptoms (withdrawal, lack of motivation)
  • Reduces suicidal tendencies

โš ๏ธ PRECAUTIONS

โ— Boxed Warnings:

  • Agranulocytosis (life-threatening low white blood cell count)
  • Seizures
  • Myocarditis (inflammation of heart muscle)
  • Orthostatic hypotension, bradycardia
  • Severe constipation or ileus

๐Ÿ’ข Common Side Effects:

  • Drowsiness
  • Salivation (drooling)
  • Weight gain
  • Dizziness
  • Constipation

๐Ÿ” Monitoring Required:

  • Complete Blood Count (CBC): Mandatory before starting and regularly during therapy
    • Weekly for first 6 months
    • Biweekly next 6 months
    • Monthly thereafter
  • ECG: If cardiac issues suspected
  • Blood pressure, weight, glucose, lipids: Regular checks

๐Ÿšซ Contraindications:

  • History of agranulocytosis
  • Uncontrolled epilepsy
  • Severe cardiac or liver disease
  • Paralytic ileus

๐Ÿ“‹ DOSING GUIDELINE (Psychiatric Use)

PhaseDose
Initial12.5 mg once or twice on day 1
TitrationIncrease by 25โ€“50 mg/day as tolerated
Maintenance300โ€“450 mg/day in divided doses
MaximumUsually โ‰ค900 mg/day (with caution)

Must be titrated slowly due to risk of hypotension and seizures.


๐ŸงŠ STORAGE

  • Store at 20โ€“25ยฐC (room temperature)
  • Protect from light, moisture, and heat
  • Keep tablets in original blister until use
  • Keep away from children
  • Handle with caution (caregiver must avoid skin contact if possible)

Leave a Comment

Your email address will not be published. Required fields are marked *

Call Now Button